Sponsor pipeline

Stemline Therapeutics, Inc. clinical trial pipeline

Get alerts when Stemline Therapeutics, Inc.'s trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-10-14 NCT07873827 KATALYST-HEME-01: Study of the KAT6 Inhibitor MEN2312 in Heme Malignancies Phase 1/2 Not Yet Recruiting

Active trials by phase

Phase 1
2
Phase 1/2
3
Phase 2
3
Phase 3
1
Not charted: 2 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials

NCT IDTitleConditionStatusUpdated
Phase 3
NCT06492616 A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2… Breast Cancer Recruiting 2026-09-15
Phase 2
NCT07766018 A Phase 2 Bridging Study of Elacestrant Monotherapy in Advanced or Metastatic Breast… Breast Cancer Recruiting 2026-10-13
NCT06456463 A Study of Tagraxofusp in Combination With Venetoclax and Azacitidine in Adults With… Acute Myeloid Leukemia Active, Not Recruiting 2026-08-06
NCT05596409 ELACESTRANT in Women and Men With CDK4/6 Inhibitor-Naive Estrogen Receptor Positive… Metastatic Breast Cancer Active, Not Recruiting 2026-05-07
Phase 1/2
NCT05386108 Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to… Breast Neoplasms Recruiting 2026-10-09
NCT07873827 KATALYST-HEME-01: Study of the KAT6 Inhibitor MEN2312 in Heme Malignancies Hematological Malignancy Not Yet Recruiting 2026-10-14
NCT05563220 Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various… Breast Cancer Active, Not Recruiting 2026-06-12
Phase 1
NCT06638307 A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer Advanced Breast Cancer Recruiting 2026-08-07
NCT07226427 A First-in-Human Study of MEN2501 in Participants With Platinum-Resistant Ovarian Cancer Platinum-resistant Ovarian Cancer Recruiting 2026-07-06
Not specified
NCT07785180 A Non-interventional Study of Participants With BPDCN Treated With Chemotherapy Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Recruiting 2026-09-15
NCT07785154 A Registry-study of ELZONRIS in Participants With BPDCN Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Recruiting 2026-08-25

Disease areas by active trials

Breast Cancer (6) · Leukemia (4) · Acute Myeloid Leukemia (AML) (2) · Ovarian Cancer (1)

Get alerts when Stemline Therapeutics, Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free